Pimavanserin is a medication used to treat hallucinations and delusions associated with Parkinson's disease. However, during the manufacturing process, impurities may be formed that can affect the drug's efficacy or cause harmful side effects. The characterization and control of these impurities are critical for ensuring the safety and quality of the drug product. Various analytical techniques, such as HPLC, LC-MS, and NMR, are used to identify and quantify these impurities. Regulatory agencies also require manufacturers to provide detailed information about the impurities present in the drug substance and drug product.
